Position in AMLX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,572,382
+$3,854,314 QoQ
Shares Held
254,587
+14.9% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 207 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. AMLX ranks #15 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in AMLX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,572,382 | 254,587 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $718,068 | 221,626 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $264,284 | 139,097 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $484,157 | 170,478 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $255,833 | 17,380 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $1,167,260 | 54,115 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $801,480 | 27,317 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,099,499 | 56,820 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||